AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension
about
A Survey of Strategies to Modulate the Bone Morphogenetic Protein Signaling Pathway: Current and Future PerspectivesChallenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the LungsMicroRNAs and mesenchymal stem cells: hope for pulmonary hypertensionEpigenetic modulation as a therapeutic approach for pulmonary arterial hypertensionMicroRNAs in respiratory disease. A clinician's overviewInflammatory cytokines in pulmonary hypertensionApelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertensionOxymiRs in cutaneous development, wound repair and regenerationA comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?Pulmonary arterial hypertension: the clinical syndrome.Therapeutic implications of microRNAs in pulmonary arterial hypertension.MicroRNA-155 potentiates the inflammatory response in hypothermia by suppressing IL-10 production.miRNA expression in control and FSHD fetal human muscle biopsiesMicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease.MicroRNAs in pulmonary arterial hypertension.Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertensionHypoxia inducible factor-1 mediates expression of miR-322: potential role in proliferation and migration of pulmonary arterial smooth muscle cells.Requirement of miR-9-dependent regulation of Myocd in PASMCs phenotypic modulation and proliferation induced by hepatopulmonary syndrome rat serumPeroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.A Functional Variant rs6435156C > T in BMPR2 is Associated With Increased Risk of Chronic Obstructive Pulmonary Disease (COPD) in Southern Chinese PopulationMicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle CellsExosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice.Featured Article: microRNA-125a in pulmonary hypertension: Regulator of a proliferative phenotype of endothelial cells.Racial differences in microRNA and gene expression in hypertensive women.Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.Discerning functional hierarchies of microRNAs in pulmonary hypertension.Canonical and non-canonical barriers facing antimiR cancer therapeuticsMicroRNAs as regulators of cutaneous wound healing.Polysome shift assay for direct measurement of miRNA inhibition by anti-miRNA drugs.Modulation of miRNAs in Pulmonary HypertensionmicroRNA and Pulmonary Hypertension.MicroRNA in the Diseased Pulmonary Vasculature: Implications for the Basic Scientist and Clinician.Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.Aquaporin 1 controls the functional phenotype of pulmonary smooth muscle cells in hypoxia-induced pulmonary hypertension.The first international workshop on the epigenetics of osteoarthritis.Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation.Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature.Critical effects of epigenetic regulation in pulmonary arterial hypertension.In Vivo Therapeutic Success of MicroRNA-155 Antagomir in a Mouse Model of Lupus Alveolar Hemorrhage.Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung.
P2860
Q26739015-B03A2BA8-F511-4AB5-B1B4-A75621E809B6Q26766294-B67E4F28-2F3F-45D1-9E92-17FF9DB93124Q26796557-C203F121-82C2-4A24-AD63-A4D4AC68C8D5Q26801345-B301641A-DD67-4880-9267-2F7F59CD64C5Q26823456-2E9EEEEF-D220-4E95-A895-F0DF6554800CQ27007510-B1B3D8C1-E14A-4536-A1FB-F6681C8A648AQ27010531-F340E255-BD69-4CE9-906E-3FA6B71C60D4Q27024906-70F3B43D-2CCF-4CAD-9584-54CC82E824FBQ27026643-B4E7BFB1-C361-4282-9C35-E6E173E52E82Q30583630-C7D986F4-789C-4DBB-A555-9E93F389A2F0Q34179986-D17B900A-80BB-4522-9A53-1B3ABB8FE89FQ34512868-F54D97FD-9FB2-4008-AF25-5D50422767E7Q35099175-BE867E8E-B376-43C2-9798-15B06EFFD65AQ35114995-8C2FD3D3-E6FC-45C7-8554-9950CF79C488Q35207669-75AF613E-828C-4E96-8F01-DE1D1879F9A5Q35770214-C069653E-3243-4BEE-B487-E953BB0D9B82Q35844570-71627B27-C5A3-4092-A959-217018DD7DE8Q36125400-44A40CAE-5F66-41F0-A254-0348BC107B7AQ36549041-8A911751-70AF-4498-BB7C-192B17934DEDQ36754116-9AD2CA66-A9F7-4B91-BB3F-B4351651D37FQ36845623-8F9664A9-3349-4D7C-9211-99F0B1533A66Q36916730-D2BA6A91-E645-43C5-B219-BB1B3948E8FAQ37071321-1125DC33-2EAD-47F8-B3DD-DCF6AC578814Q37363973-D813763D-ED05-4B47-8644-A0467835A38DQ37378211-F9AEBEA3-D176-4150-8F88-10A6A7CEFBF8Q37677437-BA0DA7F5-63DA-4A07-9682-2532F5538BE1Q38112723-EF90D6A6-1500-499A-AFC5-EC3EFF3D879EQ38213211-C142409E-5328-4417-AAEE-2EA3CFDCF1BBQ38296452-BBEF9E4C-58A1-4BDE-B407-1015D6E2DECBQ38414863-9A050F7F-71A7-4244-9699-15627E53E9B5Q38668258-F674979C-ACA2-4311-899B-51328E7FF918Q38679814-6C8996DF-5BD8-47EE-AC9E-20D035D23C18Q38779774-60B99239-D64D-4001-B0FF-857F7A65CAB7Q38837310-D152E61F-2211-4E7D-B69C-6F8230DD18CEQ38888317-5E05B917-96B5-437B-ACAA-39E2708C8EECQ39038030-9B5666B0-386A-4C78-B562-B0B8085F5E84Q39093828-0743F865-EF99-4D47-83F9-3EAEE88225FCQ39345470-0AF67599-5D1F-4EAE-827D-7EA3843C3DDFQ40335206-54492308-C859-422C-8EFC-C915EAC21A3EQ40588101-72BE5D07-20A8-4193-8349-CA9DBCD6DF5C
P2860
AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension
description
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2014
@ast
im Dezember 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2014/12/01)
@sk
vědecký článek publikovaný v roce 2014
@cs
wetenschappelijk artikel (gepubliceerd op 2014/12/01)
@nl
наукова стаття, опублікована в грудні 2014
@uk
مقالة علمية (نشرت في ديسمبر 2014)
@ar
name
AntagomiR directed against miR ...... induced pulmonary hypertension
@ast
AntagomiR directed against miR ...... induced pulmonary hypertension
@en
AntagomiR directed against miR ...... induced pulmonary hypertension
@nl
type
label
AntagomiR directed against miR ...... induced pulmonary hypertension
@ast
AntagomiR directed against miR ...... induced pulmonary hypertension
@en
AntagomiR directed against miR ...... induced pulmonary hypertension
@nl
prefLabel
AntagomiR directed against miR ...... induced pulmonary hypertension
@ast
AntagomiR directed against miR ...... induced pulmonary hypertension
@en
AntagomiR directed against miR ...... induced pulmonary hypertension
@nl
P2093
P2860
P921
P3181
P356
P1476
AntagomiR directed against miR ...... induced pulmonary hypertension
@en
P2093
Colin Schwarzwald
Lars C. Huber
Louise Ostergaard
Max Gassmann
Michelle Trenkmann
Renate E. Gay
Rudolf Speich
Silvia Ulrich
Steffen Gay
Victor J. Samillan
P2860
P304
P3181
P356
10.1093/EURHEARTJ/EHS060
P577
2014-12-01T00:00:00Z